NCT00217568View on ClinicalTrials.gov

Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2005

Primary Completion Date

March 31, 2006

Conditions
Ovarian CancerPeritoneal Cavity Cancer
Interventions
BIOLOGICAL

pegfilgrastim

DRUG

carboplatin

DRUG

docetaxel

Trial Locations (3)

98104

Pacific Gynecology Specialists, Seattle

98195

University of Washington School of Medicine, Seattle

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00217568 - Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer | Biotech Hunter | Biotech Hunter